Filing Summary
Issuer and period: This is Park City Group, Inc.’s consolidated Form 10-K, including its wholly owned ReposiTrak subsidiary—not a standalone ReposiTrak, Inc. filing. It covers the fiscal year ended June 30, 2023, with fiscal 2022 as the comparison. Although the request identifies 2022 Q4, the supplied filing is an annual report for fiscal 2023.
Business Context
Park City Group provides cloud-based SaaS for retailers, wholesalers, distributors, and suppliers, primarily in food-related markets. Its ReposiTrak platform offers supplier discovery and B2B commerce, compliance and food safety, and supply-chain management services, generally using a hub-and-spoke model. Revenue is primarily recurring subscriptions, support, and services.
Financial Results and Liquidity
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Revenue | $19.10 million | $18.05 million | +6% |
| Operating income | $5.09 million | $4.41 million | +15% |
| Net income | $5.59 million | $4.00 million | +40% |
| Net income applicable to common shareholders | $5.00 million | $3.42 million | +46% |
| Basic and diluted EPS | $0.27 | $0.18 | Up $0.09 |
| Cash provided by operating activities | $8.86 million | $6.10 million | +45% |
- Recurring subscription, support, and services revenue was $19.03 million, up 7%; non-recurring services revenue was $69,917, and transaction-based revenue was zero, compared with $108,254 in FY2022.
- Cost of revenue and product support was 17% of revenue versus 18% in FY2022, implying a gross margin of approximately 83% versus 82%. Operating margin was approximately 26.7% versus 24.5%; net margin was approximately 29.3% versus 22.2%.
- Cash and cash equivalents were $23.99 million, up 12%. Working capital was $23.04 million, and the current ratio was 6.44, compared with 4.36 a year earlier.
- The company reported no bank debt at year-end. It had approximately $425,000 of notes payable and financing-lease liabilities, in addition to operating lease liabilities. A $10 million revolving credit facility was available subject to covenants, including a $12 million liquidity requirement.
- Investing activities used $903,187, including $769,243 of capitalized software development costs. Financing activities used $5.43 million, including $2.59 million to pay down the line of credit, $1.31 million for common-stock repurchases, and $1.41 million of dividends paid.
Material Changes and Unusual Items
- Revenue growth reflected increased recurring subscription, services, and other recurring revenue, particularly in compliance and supply chain. Management attributed demand partly to growing food-safety and traceability requirements.
- FY2022 Marketplace revenue included pandemic-related sourcing of hard-to-find products, including personal protective equipment. The filing says future demand for such products is uncertain.
- Other income improved to $821,082 from a $281,558 net expense, primarily due to higher interest income on cash and investments. FY2022 included $347,645 of realized losses on short-term investments; FY2023 included $9,752 of unrealized investment losses.
- General and administrative expense included the benefit of approximately $1.175 million in Employee Retention Credit payroll-tax refunds, net of fees. The benefit was partly offset by higher bad-debt, employee-benefit, and payroll costs. Bad-debt expense was $1.30 million, up from $621,667.
- Management reported additional cybersecurity and infrastructure investment, including $327,323 in hardware and software during the year. Capitalized software development related in part to the ReposiTrak Traceability Network.
- On September 12, 2023, the company announced a plan to redeem and retire its Series B and Series B-1 preferred stock for $10.70 per share, an aggregate $8.96 million over three years. The board also declared a quarterly common dividend of $0.015 per share, or $0.06 annually.
Outlook, Risks, and Contingencies
- Management said cash, short-term investments, and operating cash generation should fund operations and investment needs for at least 12 months, including anticipated common dividends and the planned preferred-stock redemption. It expects cash flow and working capital to increase, but gave no quantified revenue or earnings guidance.
- Management sees potential demand from FSMA Section 204 food-traceability requirements and is developing its traceability offering. Adoption could be slower if implementation is delayed, requirements change, or industry compliance is slow.
- Other principal risks include customer renewals and spending, competition from larger vendors, product defects or service interruptions, cybersecurity and data breaches, economic and geopolitical uncertainty, and reliance on founder and CEO Randall K. Fields. The company also notes its limited public trading market and significant insider control.
- The filing reports no pending or threatened material legal proceedings and no material off-balance-sheet arrangements. The audited financial statements received an unqualified opinion. Revenue recognition for multiple-element arrangements was identified as a critical audit matter; the auditor did not express a separate opinion on that matter.
Most Important Facts to Verify
- Confirm the fiscal-year scope and issuer: the supplied filing is Park City Group’s FY2023 10-K, not a FY2022 Q4 report or a standalone ReposiTrak filing.
- Assess how much FY2023 earnings and cash generation depended on the one-time ERC refund, higher investment interest income, and working-capital movements.
- Review the $1.30 million bad-debt expense, receivable allowance, and the customer representing more than 10% of accounts receivable ($962,300 at both year-ends).
- Check the timing, funding, and effect of the $8.96 million preferred-stock redemption, continuing preferred dividends, and common-stock dividends.
- Track recurring subscription growth, customer retention, and actual adoption and monetization of the FSMA 204 traceability offering; the filing provides no quantified forecast.